Global bioenergies
-
Upload
globalbioenergies -
Category
Business
-
view
532 -
download
3
description
Transcript of Global bioenergies
Converting renewable resources into hydrocarbons
Marc Delcourt, CEOJune 2010
Global Bioenergies
• Est. 2008 by Marc Delcourt and Philippe Marlière
• Located close to Paris on the Genopole Campus
• 20 people
• Venture capital funded
• R&D facilities > 700 m2
06/2010 2
Diverse feedstocks…
06/2010 3
Sugar cane
Sugar beet
Sugar 170mT
Starch 2.070mT
Wheat
Corn
Rye, rice, barley, Potatoes….
Ligno-celluloseTo be industrialised in
the near futurePotential: x10.000mT
Straw
Forestry waste
Energy crops
… transformed into isobutene
• Reduced costs and increased GHG savings due to: – No product inhibition
– No distillation or solvent extraction
4
High purityIsobutene
Low qualityGlucose
Genetically engineered micro-organism
06/2010
Isobutene: products tree
Isobutene
Glucose
5
Isooctane
Jet fuel
Diesel
Flavors, dyes
ETBE
Tires
Organic glass
Plastics
Textiles
06/2010
Gaseous hydrocarbons
• Except methane, gaseous hydrocarbons are not produced by living organisms
• Bioproduction of gaseous hydrocarbons from renewable resources involves designing artificial metabolic pathways
• Using a new and innovative Synthetic Biology approach, we have designed such an artificial pathway, based on:– non-natural metabolites
– undescribed enzyme activities
06/2010 6
Present state of development
7
A
C
B
optimisation Strain construction Scale-up
A
C
B
discovery
I n p r o g r e s s
06/2010
Factory modelisation (Europe)
06/2010 8
• 350kT per yr• 40 000 ha,
(cultivated disc 15km radius)
• Mill• Fermentation• Secondary conversion
• 100 kT per yr• Local distribution
Green House Gas savings
Improved fermentation and no distillation leads to an improved environmental impact
Gaseous fermentation could lead to the only compliant fuel produced from sugar or starch in accordance with EU directives 2017-18
9
Oil
CO2
em
issi
on p
er M
J
GBE’s hydrocarbonsEthanol
US corn Brazilian caneEU beetEU wheat
Request to obtain tax incentives in the EU
Present: -35%
2017: -50%2018: -60%
06/2010
Summary
• Proof of concept on artificial pathway to isobutene
• A new synthetic biology strategy, based on « hyposteric » substrates
• Commercialization within 5 years
• Only player in Europe (4 competitors in the US)
• In progress: pathways to other terminal alkenes (propylene, ethylene, other butenes…) totalling a market of >$200b
06/2010 10
www.global-bioenergies.com